{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:40:29Z","timestamp":1761946829689},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1245\/s10434-019-07740-x","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T20:04:53Z","timestamp":1566504293000},"page":"4100-4107","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dynamic Changes in Normal Liver Parenchymal Volume During Chemotherapy for Colorectal Cancer: Liver Atrophy as an Alternate Marker of Chemotherapy-Associated Liver Injury"],"prefix":"10.1245","volume":"26","author":[{"given":"Junichi","family":"Shindoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kinowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Mise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Gonoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kuroyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"7740_CR1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/jso.21657","volume":"102","author":"A Brouquet","year":"2010","unstructured":"Brouquet A, Nordlinger B. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials. J Surg Oncol. 2010;102:932\u20136.","journal-title":"J Surg Oncol."},{"key":"7740_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11605-013-2369-0","volume":"18","author":"J Shindoh","year":"2014","unstructured":"Shindoh J, Tzeng CW, Aloia TA, et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014;18:45\u201351.","journal-title":"J Gastrointest Surg."},{"key":"7740_CR3","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","volume":"17","author":"Y Kishi","year":"2010","unstructured":"Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010;17:2870\u20136.","journal-title":"Ann Surg Oncol."},{"key":"7740_CR4","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1245\/s10434-012-2864-7","volume":"20","author":"J Shindoh","year":"2013","unstructured":"Shindoh J, Tzeng CW, Aloia TA, et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013;20:2493\u2013500.","journal-title":"Ann Surg Oncol."},{"key":"7740_CR5","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"JN Vauthey","year":"2006","unstructured":"Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065\u201372.","journal-title":"J Clin Oncol."},{"key":"7740_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/SLA.0b013e3182738204","volume":"256","author":"F Cauchy","year":"2012","unstructured":"Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256:746\u201352 (discussion 752\u20134).","journal-title":"Ann Surg."},{"key":"7740_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00268-014-2799-1","volume":"39","author":"TM Lodewick","year":"2015","unstructured":"Lodewick TM, de Jong MC, van Dam RM, et al. Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases. World J Surg. 2015;39:478\u201386.","journal-title":"World J Surg."},{"key":"7740_CR8","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","volume":"28","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Maru DM, Charnsangavej C, et al. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010;28:2549\u201355.","journal-title":"J Clin Oncol."},{"key":"7740_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460\u20136.","journal-title":"Ann Oncol."},{"key":"7740_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2012.10.018","volume":"216","author":"J Shindoh","year":"2013","unstructured":"Shindoh J, Truty MJ, Aloia TA, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216:201\u20139.","journal-title":"J Am Coll Surg."},{"key":"7740_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/bjs.5836","volume":"94","author":"D Ribero","year":"2007","unstructured":"Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386\u201394.","journal-title":"Br J Surg."},{"key":"7740_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11605-017-3359-4","volume":"21","author":"K Tani","year":"2017","unstructured":"Tani K, Shindoh J, Takamoto T, et al. Kinetic changes in liver parenchyma after preoperative chemotherapy for patients with colorectal liver metastases. J Gastrointest Surg. 2017;21:813\u201321.","journal-title":"J Gastrointest Surg."},{"key":"7740_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11605-017-3467-1","volume":"22","author":"K Omichi","year":"2018","unstructured":"Omichi K, Yamashita S, Cloyd JM, et al. Portal vein embolization reduces postoperative hepatic insufficiency associated with postchemotherapy hepatic atrophy. J Gastrointest Surg. 2018;22:60\u20137.","journal-title":"J Gastrointest Surg."},{"key":"7740_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.1840210515","volume":"21","author":"K Urata","year":"1995","unstructured":"Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317\u201321.","journal-title":"Hepatology."},{"key":"7740_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology."},{"key":"7740_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/jnci\/djx288","volume":"110","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Ferrarotto R, Raghav K, et al. The addition of bevacizumab to oxaliplatin-based chemotherapy: impact upon hepatic sinusoidal injury and thrombocytopenia. J Natl Cancer Inst. 2018;110:888\u201394.","journal-title":"J Natl Cancer Inst."},{"key":"7740_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","volume":"35","author":"M Klinger","year":"2009","unstructured":"Klinger M, Eipeldauer S, Hacker S, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol. 2009;35:515\u201320.","journal-title":"Eur J Surg Oncol."},{"key":"7740_CR18","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/cncr.23099","volume":"110","author":"D Ribero","year":"2007","unstructured":"Ribero D, Wang H, Donadon M, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007;110:2761\u20137.","journal-title":"Cancer."},{"key":"7740_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ejso.2016.02.017","volume":"42","author":"J Martins","year":"2016","unstructured":"Martins J, Alexandrino H, Oliveira R, et al. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM\u2014protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor. Eur J Surg Oncol. 2016;42:713\u201321.","journal-title":"Eur J Surg Oncol."},{"key":"7740_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.surg.2003.08.024","volume":"135","author":"EK Abdalla","year":"2004","unstructured":"Abdalla EK, Denys A, Chevalier P, et al. Total and segmental liver volume variations: implications for liver surgery. Surgery. 2004;135:404\u201310.","journal-title":"Surgery."},{"key":"7740_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/hpb.12157","volume":"16","author":"Y Mise","year":"2014","unstructured":"Mise Y, Satou S, Shindoh J, et al. Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford). 2014;16:439\u201347.","journal-title":"HPB (Oxford)."},{"key":"7740_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.hpb.2018.12.001","volume":"21","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Kiya Y, Sugawara T, et al. Expanded Makuuchi\u2019s criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB (Oxford). 2019;21:990\u20137.","journal-title":"HPB (Oxford)."},{"key":"7740_CR23","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/bjs.7084","volume":"97","author":"Y Yokoyama","year":"2010","unstructured":"Yokoyama Y, Nishio H, Ebata T, et al. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260\u20138.","journal-title":"Br J Surg."},{"key":"7740_CR24","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"VJ Desmet","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513\u201320.","journal-title":"Hepatology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07740-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:16:45Z","timestamp":1597965405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07740-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["7740"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07740-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"16 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Junichi Shindoh reports receiving honoraria from Chugai and Takeda. No other authors reported disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}